Literature DB >> 12486319

Serum soluble interleukin-2 receptor in eosinophilia.

Ken Kaito1, Hiroko Otsubo, Yoji Ogasawara, Hiroko Kimura, Etsuko Kurihara, Masaru Koike, Masayoshi Aiso, Masayuki Kobayashi.   

Abstract

The relationship between soluble interleukin-2 receptor (sIL-2R) levels and clinical characteristics was evaluated in patients with eosinophilia. Thirty-eight out of 60 patients showed sIL-2R levels of more than 800 U/ml. In these patients, sIL-2R was closely related to the eosinophil count, but not the IgE level. Their underlying diseases were heterogeneous, including neoplasms and collagen diseases. In patients with lower sIL-2R levels, there was no relationship to the eosinophil count, but sIL-2R was correlated with the IgE level. These findings indicate that patients with eosinophilia and higher sIL-2R levels tend to have underlying diseases other than allergy, and might be more severely ill than patients with lower sIL-2R levels. sIL-2R may be a good marker for evaluating patients with eosinophilia, as an indicator of the probable etiology and severity of their diseases. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12486319     DOI: 10.1159/000067274

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  2 in total

1.  The increase of plasma galectin-9 in a patient with insulin allergy: a case report.

Authors:  Haorile Chagan-Yasutan; Beata Shiratori; Umme Ruman Siddiqi; Hiroki Saitoh; Yugo Ashino; Tomohiro Arikawa; Mitsuomi Hirashima; Toshio Hattori
Journal:  Clin Mol Allergy       Date:  2010-08-11

2.  Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro.

Authors:  Eric R Secor; Anurag Singh; Linda A Guernsey; Jeff T McNamara; Lijun Zhan; Nilanjana Maulik; Roger S Thrall
Journal:  Int Immunopharmacol       Date:  2009-01-20       Impact factor: 4.932

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.